The Discounted Cash Flow (DCF) valuation of MabCure Inc (MBCI) is (6.56) USD. With the latest stock price at 0.00 USD, the upside of MabCure Inc based on DCF is -6563613.8%.
Based on the latest price of 0.00 USD and our DCF valuation, MabCure Inc (MBCI) is a sell. selling MBCI stocks now will result in a potential gain of 6563613.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
WACC / Discount Rate | 3.0% - 6.5% | 4.7% |
Long-term Growth Rate | 2.0% - 2.8% | 2.4% |
Fair Price | (60.69) - (3.52) | (6.56) |
Upside | -60690979.6% - -3523641.5% | -6563613.8% |